HY-101189-1mg
|
MedChemexpress LLC
|
JNJ-39758979 [CAS 1046447-90-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101189-10mg
|
MedChemexpress LLC
|
JNJ-39758979 [CAS 1046447-90-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101189-100mg
|
MedChemexpress LLC
|
JNJ-39758979 [CAS 1046447-90-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101189-5mg
|
MedChemexpress LLC
|
JNJ-39758979 [CAS 1046447-90-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101189-50mg
|
MedChemexpress LLC
|
JNJ-39758979 [CAS 1046447-90-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101760-1mg
|
MedChemexpress LLC
|
GSK2982772 [CAS 1622848-92-3]
|
|
COVID-19-immunoregulation
|
|
HY-101760-10mg
|
MedChemexpress LLC
|
GSK2982772 [CAS 1622848-92-3]
|
|
COVID-19-immunoregulation
|
|
HY-101760-100mg
|
MedChemexpress LLC
|
GSK2982772 [CAS 1622848-92-3]
|
|
COVID-19-immunoregulation
|
|
HY-101760-5mg
|
MedChemexpress LLC
|
GSK2982772 [CAS 1622848-92-3]
|
|
COVID-19-immunoregulation
|
|
HY-101760-50mg
|
MedChemexpress LLC
|
GSK2982772 [CAS 1622848-92-3]
|
|
COVID-19-immunoregulation
|
|
HY-101879-100mg
|
MedChemexpress LLC
|
Acridine Orange (hydrochloride) [CAS 65-61-2]
|
|
|
|
HY-10656-10mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-10656-100mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-10656-25mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-10656-5mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-10656-50mg
|
MedChemexpress LLC
|
SB-657510 [CAS 474960-44-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-108446-10mg
|
MedChemexpress LLC
|
GSK 1562590 (hydrochloride) [CAS 1003878-07-6]
|
|
|
|
HY-108446-50mg
|
MedChemexpress LLC
|
GSK 1562590 (hydrochloride) [CAS 1003878-07-6]
|
|
|
|
HY-108446-5mg
|
MedChemexpress LLC
|
GSK 1562590 (hydrochloride) [CAS 1003878-07-6]
|
|
|
|
HY-109114-1mg
|
MedChemexpress LLC
|
Dersimelagon [CAS 1835256-48-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-109114-5mg
|
MedChemexpress LLC
|
Dersimelagon [CAS 1835256-48-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-110210-1mg
|
MedChemexpress LLC
|
BODIPY-FL NHS ester [CAS 146616-66-2]
|
|
|
|
HY-110210-10mg
|
MedChemexpress LLC
|
BODIPY-FL NHS ester [CAS 146616-66-2]
|
|
|
|
HY-110210-5mg
|
MedChemexpress LLC
|
BODIPY-FL NHS ester [CAS 146616-66-2]
|
|
|
|
HY-110250-10mg
|
MedChemexpress LLC
|
DFHBI [CAS 1241390-29-3]
|
|
|
|